SavedAdd your journal

Journals / Glokom Katarakt / 2020 / Cilt: 15 - Sayı: 1

QUEST EDITORIALSNanophthalmos and Glaucoma

Selin DOĞANAT
Derya DOĞANAT
Pages
1–7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, the clinical and therapeutic approaches of glaucoma-nanophthalmos will be reviewed in the light of the literature

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nanophthalmos is an uncommon, bilateral and developmental ocular disease and is usually genetic.
📊
Key Findings & Data:The patients may experience serious ocular problems such as glaucoma and uveal effusion syndrome, especially in the third–fi fth decades of their lives.
💡
Conclusion & Impact:In this study, the clinical and therapeutic approaches of glaucoma-nanophthalmos will be reviewed in the light of the literature
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Nanophthalmos is an uncommon, bilateral and developmental ocular disease and is usually genetic. The patients may experience serious ocular problems such as glaucoma and uveal effusion syndrome, especially in the third–fi fth decades of their lives. Surgical management of glaucoma in patients with nanophthalmos is quite diffi cult. Serious complications can occur during or after the glaucoma surgery in patients with nanophthalmic eyes. In this study, the clinical and therapeutic approaches of glaucoma-nanophthalmos will be reviewed in the light of the literature

🔖

Cite This Article

DOĞANAT, S., DOĞANAT, D. (2020). QUEST EDITORIALSNanophthalmos and Glaucoma. Glokom Katarakt, Cilt: 15 - Sayı: 1, 1–7. https://ajindex.com/articles/226903

References (15)

  1. Carricondo PC, Andrade T, Prasov L, et al. Nanophthalmos: A review of the clinical spectrum and genetics. J Ophthalmol. 2018 May 9;2018:2735465. doi: 10.1155/2018/2735465. eCollection 2018
  2. Elder MJ. Aetiology of severe visual impairment and blindness in microphthalmos. Br J Ophthalmol. 1994;78:332-4
  3. Srinivasan S, Batterbury M, Marsh IB, et al. Corneal topographic features in a family with nanophthalmos. Cornea.2006;25:750-6
  4. Walsh MK, Goldberg MF. Abnormal foveal avascular zone in nanophthalmos. Am J Ophthalmol. 2007;143:1067-8
  5. Crespí J, Buil JA, Bassaganyas F, Vela-Segarra JI, et al. A novel mutation confi rms MFRP as the gene causing the syndrome of nanophthalmos-renititis pigmentosa-foveoschisis-optic disk drusen. Am J Ophthalmol. 2008;146:323-8
  6. Zacharias LC, Susanna R Jr, Sundin O. Effi cacy of topical dorzolamide therapy for cystoid macular edema in a patient with MFRP-related nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen syndrome. Retin Cases Brief Rep. 2015;9:61-3
  7. MacKay CJ, Shek MS, Carr RE, et al. Retinal degeneration with nanophthalmos, cystic macular degeneration, and angle closure glaucoma. A new recessive syndrome. Arch Ophthalmol. 1987;105:366-71
  8. Albar AA, Nowilaty SR, Ghazi NG. Nanophthalmos and hemiretinal vein occlusion: A case report. Saudi J Ophthalmol. 2015;29:89-91
  9. Demircan A, Altan C, Osmanbasoglu OA, et al. Subfoveal choroidal thickness measurements with enhanced depth imaging optical coherence tomography in patients with nanophthalmos. Br J Ophthalmol. 2014;98:345-9
  10. Xiao H, Guo X, Zhong Y, et al. Retinal and choroidal changes of nanophthalmic eyes with and without secondary glaucoma. Retina.2015;35:2121-9
  11. Helvacioglu F, Kapran Z, Sencan S, et al. Optical coherence tomography of bilateral nanophthalmos with macular folds and high hyperopia. Case Rep Ophthalmol Med. 2014;2014:173853
  12. Relhan N, Jalali S, Pehre N, et al. High-hyperopia database, part I: clinical characterisation including morphometric (biometric) differentiation of posterior microphthalmos from nanophthalmos. Eye (Lond).2016;30:120-6
  13. Khan AO. Posterior microphthalmos versus nanophthalmos. Ophthalmic Genet. 2008;29:189
  14. Wu W, Dawson DG, Sugar A, et al. Cataract surgery in patients with nanophthalmos: results and complications. Cataract Refract Surg. 2004;30:584-90
  15. Yalvac IS, Satana B, Ozkan G, et al. Management of glaucoma in patients with nanophthalmos. Eye (Lond). 2008;22:838-43